ENERGY SHOT BEVERAGE BRAND BUSINESS PLAN
I. Executive Summary
Company Description
PeakPulse — named to signal short, intense bursts of focused energy — is a U.S.-based functional beverage company launching in 2026 and headquartered in Austin, Texas. We operate in the beverage and wellness sector and sell 2-ounce concentrated energy shots designed for clean, fast cognitive and physical uplift. We use a co-packing model to keep fixed costs low, scale quickly, and focus on product development, distribution, and brand marketing. One-liner: we deliver clinical-strength, portable energy for high performers.
Our products combine clinically dosed nootropics, clean stimulants, and natural flavors to serve professionals, entrepreneurs, athletes, and students seeking productivity without crash. Main activities: formula R&D, co-packer coordination, direct-to-consumer and wholesale distribution, and targeted digital and campus marketing. We project growth from an initial $1.54M to $20.37M in five years. Short-term goal: achieve product-market fit and $1.5M ARR in year one; long-term goal: category leadership and national retail placement by year five.
Problem
Professionals and students suffer from persistent mental fatigue and daily brain fog that reduce focus and productivity. Existing portable options are inadequate: full-size energy drinks are bulky, many contain high sugar that causes insulin-driven crashes, and some products use synthetic stimulants that create jittery side effects. Consumers lack a small, on-the-go solution that delivers immediate cognitive clarity without sugar crashes or stimulant jitters.
The market gap requires a compact, clean-energy shot to restore focus for health-conscious, high-performing users. The company targets $1,540,000 revenue in 2026 by addressing this unmet need with 2-ounce concentrated shots produced via co-packing for rapid scalability.
Solution
Modern professionals face fatigue and mental fog but reject large, sugary energy drinks that cause jitters and crashes. Our product answers this with 2-ounce concentrated energy shots that deliver sustained alertness using clean botanical caffeine and a B‑vitamin complex, with zero added calories and no refrigeration required.
We offer five purpose-driven variants calibrated for dose, flavor, and function to match use cases like pre-workout, mid-afternoon focus, late-night study, long drives, and quick meeting recoveries; the format is pocketable and clinically dosed for reliable, rapid-onset performance.
Financial target: U.S. launch projects EBITDA of $497,000 in year one. One-liner: compact, zero-calorie shots that sustain focus and energy.
Mission Statement
We empower high-performing individuals to maximize daily productivity with clean, scientifically formulated portable energy shots that support mental and physical excellence without compromise. We commit to convenient, health-conscious products grounded in transparency, quality, and innovation, and to becoming the premier choice for portable energy in the U.S. by 2030. We deliver exceptional customer value and target a 29.08% IRR for stakeholders.
Key Success Factors
These critical factors drive our early stability, scaleability, and profitability.
-
2-month breakeven delivers rapid cash-flow stability and low runway risk.
-
Proprietary formulas plus $10,000 in trademarks create a defensible product position.
-
FDA-registered co-packer enables scaling to 5,300,000 units by Year 5 without major capex.
-
8.0% marketing allocation secures high digital visibility in a competitive landscape.
-
27.97% Return on Equity demonstrates strong unit economics and investor appeal.
Financial Summary
Financial Summary for the Executive Summary: first-year revenue of $1,540,000 and EBITDA of $497,000 with rapid scale to Year 3 and Year 5.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | $1,540,000 | $3,809,000 | $7,755,000 |
Projected EBITDA | $497,000 | $1,807,000 | $4,128,000 |
Expected ROI | 29.08% | 29.08% | 29.08% |
Financial requirements: initial capex of $162,000 and working capital to maintain a minimum cash balance of $1,149,000; anticipated return uses an internal rate of return of 29.08% and a 6-month payback period.
Outlook: strong revenue and EBITDA growth with early breakeven (Feb-26) and high investor returns.
Funding Requirements
$1,149,000 funds launch, reaches breakeven in Feb-26, and returns capital within 6 months while supporting Year 1 revenue of $1,540,000 and EBITDA of $497,000.
Categories | Amount, USD |
Pre-launch capex (total capex items) | $162,000 |
Product Development (included in capex) | $45,000 |
Website and E‑commerce (included in capex) | $35,000 |
Branding & Packaging Design (included in capex) | $20,000 |
Initial Office & Lab Equipment (included in capex) | $15,000 |
Marketing (8.0% of Year 1 revenue) | $123,200 |
Working capital (first two months) | $863,800 |
Working capital | $863,800 |
Total funding required | $1,149,000 |